Kaleido Competitors

KLDO -  USA Stock  

USD 5.45  0.07  1.30%

Kaleido Biosciences competes with Dynavax Technologies; as well as few others. The company conducts business under Healthcare sector and is part of Biotechnology industry. Analyzing Kaleido Biosciences competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Kaleido Biosciences to its intrinsic valuation because they are able to contrast its competitors on a relative basis.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Kaleido Biosciences competition on your existing holdings. Please see Kaleido Biosciences Correlation with its peers.

Search Competition 

 
Refresh
The value of Return on Average Assets is estimated to slide to -1.23. The value of Return on Average Equity is estimated to slide to -2.37. Kaleido Biosciences Total Assets are quite stable at the moment as compared to the past year. The company's current value of Total Assets is estimated at 68.54 Million. Current Assets is expected to rise to about 58.5 M this year, although the value of Assets Non Current will most likely fall to about 10.1 M.

Specify up to 10 symbols:

Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Kaleido Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Kaleido Biosciences in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
2.445.548.64
Details
Intrinsic
Valuation
LowReal ValueHigh
4.347.4410.54
Details
5 Analysts
Consensus
LowTarget PriceHigh
5.0014.6022.00
Details
Earnings
Estimates (4)
LowProjected EPSHigh
-2.63-2.31-2
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Kaleido Biosciences. Your research has to be compared to or analyzed against Kaleido Biosciences' peers to derive any actionable benefits. When done correctly, Kaleido Biosciences' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Kaleido Biosciences.

Kaleido Biosciences Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Kaleido Biosciences and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Kaleido and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Kaleido Biosciences does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Kaleido Biosciences Competition Risk-Adjusted Indicators

Nowadays, there is a big difference between Kaleido Biosciences stock performing well and Kaleido Biosciences company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Kaleido Biosciences' multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean
Deviation
Jensen
Alpha
Sortino
Ratio
Treynor
Ratio
Semi
Deviation
Information
Ratio
Expected
Shortfall
Potential
Upside
Value
At Risk
Maximum
Drawdown
TWTR
 1.40  0.02  0.01  0.03  1.81  0.0081 (1.44)  3.18 (3.09)  9.37 
MSFT
 0.71  0.23  0.41  0.44  0.04  0.26 (0.95)  1.68 (0.90)  3.56 
UBER
 1.60 (0.42)  0.00 (0.57)  0.00 (0.22)  0.00  3.01 (2.90)  7.15 
F
 1.51 (0.19)  0.00 (0.10)  0.00 (0.09)  0.00  3.40 (2.88)  9.74 
T
 0.61 (0.10)  0.00 (0.11)  0.00 (0.13)  0.00  1.00 (1.49)  3.91 
A
 0.65  0.27  0.30  1.11  0.46  0.29 (0.78)  1.68 (0.91)  5.73 
CRM
 0.86  0.07  0.06  0.81  0.87  0.05 (0.93)  2.52 (1.55)  5.00 
JPM
 1.03 (0.01)  0.00  0.00  1.33 (0.0051) (1.04)  2.06 (2.28)  6.45 
MRK
 0.67 (0.06)  0.00 (0.16)  0.00 (0.09)  0.00  1.20 (1.46)  3.62 
XOM
 1.41 (0.16)  0.00 (0.08)  0.00 (0.08)  0.00  3.37 (2.85)  7.08 

Cross Equities Net Income Analysis

Compare Kaleido Biosciences and related stocks such as Dynavax Technologies Net Income Over Time
Select Fundamental

201020112012201320142015201620172018201920202021
DVAX
(57.3 M)(48.6 M)(69.9 M)(66.7 M)(90.7 M)(106.8 M)(112.4 M)(95.2 M)(158.9 M)(152.6 M)(75.2 M)(81.2 M)

Kaleido Biosciences and related stocks such as Dynavax Technologies Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Kaleido Biosciences financial statement analysis. It represents the amount of money remaining after all of Kaleido Biosciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of Net Income Available to Non-controlling Interests from Consolidated Income; and before the deduction of Preferred Dividends.

Kaleido Biosciences Competitive Analysis

The better you understand Kaleido Biosciences competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Kaleido Biosciences' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Kaleido Biosciences' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
KLDO
DVAX
 1.30 
 5.45 
 0.28 
 14.44 
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Stock Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Trade Advice
(90 Days Macroaxis Advice)
Number of Shares Shorted
Shares Owned by Insiders
Current Ratio
Profit Margin
EBITDA
Current Valuation
Cash Flow from Operations
Operating Margin
Retained Earnings
Current Asset
Beta
Price to Book
Shares Outstanding
Total Debt
Return On Equity
Price to Earning
Z Score
Shares Owned by Institutions
Return On Asset
Book Value Per Share
Cash and Equivalents
Current Liabilities
Total Asset
Short Ratio
Price to Sales
Market Capitalization
Cash per Share
Net Income
Earnings Per Share
Debt to Equity
Revenue
Working Capital
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Kaleido Biosciences Competition Performance Charts

Complement your Kaleido Biosciences position

In addition to having Kaleido Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Social Domain Thematic Idea Now

Social Domain
Social Domain Theme
New or established large and mid-sized companies that are involved in the social media industry, including entities that provide web-based or mobile media applications and services across across large segment of population in multiple geographical areas. Social Domain theme has 35 constituents.
View All  Next Launch Social Domain
Please see Kaleido Biosciences Correlation with its peers. Note that the Kaleido Biosciences information on this page should be used as a complementary analysis to other Kaleido Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Watchlist Optimization module to optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm.

Complementary Tools for Kaleido Stock analysis

When running Kaleido Biosciences price analysis, check to measure Kaleido Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kaleido Biosciences is operating at the current time. Most of Kaleido Biosciences' value examination focuses on studying past and present price action to predict the probability of Kaleido Biosciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Kaleido Biosciences' price. Additionally, you may evaluate how the addition of Kaleido Biosciences to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
The market value of Kaleido Biosciences is measured differently than its book value, which is the value of Kaleido that is recorded on the company's balance sheet. Investors also form their own opinion of Kaleido Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Kaleido Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kaleido Biosciences' market value can be influenced by many factors that don't directly affect Kaleido Biosciences underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kaleido Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Kaleido Biosciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kaleido Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.